Tech News, Magazine & Review WordPress Theme 2017
  • Home
  • Supply Chain Updates
  • Global News
  • Contact Us
  • Home
  • Supply Chain Updates
  • Global News
  • Contact Us
No Result
View All Result
No Result
View All Result
Home Supply Chain Updates

Cellular survival over genomic perfection

usscmc by usscmc
November 15, 2019
Cellular quality control by the ubiquitin-proteasome system and autophagy
Share on FacebookShare on Twitter

Damage to DNA occurs continuously. DNA quality control mechanisms, such as DNA repair and replicative pathways, mitigate that damage and preserve the DNA sequence. Mutations are believed to arise when DNA lesions are not repaired appropriately, and they are thought to be an indicator of ineffectual DNA quality control. Yet, DNA sequencing of normal tissues reveals that considerable somatic mutagenesis is common. Mutagenesis appears to be the inevitable outcome of cellular wear and tear and is not necessarily cancer associated. Perhaps mutagenesis is not due to failings of DNA quality control mechanisms. Rather, such pathways may be naturally limited in activity, resulting in permissiveness to mutagenesis. We suggest that this is a prioritization of survival over genomic perfection, given that most DNA damage is inconsequential and thus, affordable.

Water and oxygen are highly mutagenic to DNA, but essential for life (1). Hydrolysis and oxidation continuously cause DNA modifications that could become permanently embedded in the genome, as mutation (1). In addition to endogenous sources of DNA damage, DNA is regularly exposed to environmental genotoxins such as ultraviolet (UV) radiation or tobacco smoke. DNA damage is thus inevitable. DNA quality control pathways survey and fix the genome to mitigate damage (2, 3). DNA damage, such as double-strand breaks, are poorly tolerated and if unfixed, can induce cell death (2, 3). Moreover, DNA damage checkpoints, which pause cell division to allow time for DNA repair, highlight that maintaining DNA integrity prior to cell division is vital for cell survival (4). Comprehensive DNA quality control pathways are therefore considered crucial to preserving genomic health.

The biologist Theodor Boveri hypothesized that aggregations of heritable material, later called chromosomes, were associated with cancer. His work lay the foundations for the somatic mutation theory of carcinogenesis, in which stepwise acquisition of mutations are believed to be central to the development of cancer (5). Through statistical analyses of inherited versus sporadic retinoblastoma, Alfred Knudson hypothesized that two “hits” to DNA (driver mutations) were necessary to cause cancer. This explained early, childhood onset of heritable retinoblastoma, because the first mutation was inherited. A raft of “driver” mutation discoveries soon followed. Cancers carry only a handful (less than 10 per tumor) of causally implicated driver mutations that occur in “cancer genes,” so-called because these genes are recurrently mutated across many tumors. This buttressed the somatic mutation theory and was instrumental to the development of targeted therapeutics.

Cancer cells also carry thousands of “passenger” mutations believed to be bystander events devoid of biological effects. Passenger mutations are thought to arise because of incompetencies of DNA quality control pathways to adequately fix DNA damage (6). Indeed, an early step in tumorigenesis has been proposed to be the induction of a “mutator phenotype” (6). Large-scale cancer genome sequencing efforts have revealed the extraordinary extent of mutagenesis such that extensive genetic changes are considered pathognomonic of cancer.

Recently, somatic mutations, including driver mutations and high numbers of passenger mutations, were found to occur in normal tissue with no sign of cancer, implying that mutagenesis could be extensive in normal cells, prior to malignant transformation (7). Notably, samples of redundant eyelid skin removed at blepharectomy were used for ultra-deep sequencing of 74 cancer genes, and characteristic mutations associated with skin cancer (e.g., melanoma) were found in these nonmalignant tissues. Qualitative mutational signatures of UV radiation–induced damage were also appreciable, and the quantitative burden of mutagenesis in normal skin was comparable to that of skin cancers (8). Moreover, ultra-deep targeted sequencing of normal esophageal epithelium discerned hundreds of mutated clonal cell populations per square centimeter. The cancer gene NOTCH1 was one of the most commonly mutated genes in normal esophageal epithelium, with a frequency exceeding that observed in esophageal cancers (9, 10). In a comprehensive analysis of RNA sequencing data from >6000 samples of 29 healthy tissue types (11), cancer-associated mutations were found across tissues, levels of mutagenesis were associated with exposure to exogenous mutagens and tissue-specific proliferation rates, and macroscopic clonal expansions were also demonstrable. Hence, driver mutations, widespread mutagenesis, and even a mélange of competitive clones are all compatible with normal tissue and are not necessarily associated with cancer (see the figure).

The high number of passenger mutations, equivalent to 1000 to 10,000 per genome, in normal cells (8, 12) raises questions regarding why DNA quality control mechanisms have failed to limit mutagenesis. Perhaps a somewhat counterintuitive perspective (13) can be considered: If DNA quality control pathways monitor and preserve DNA integrity too strictly, it could be detrimental to cellular survival. The repair of DNA lesions has a cost: It requires time and cellular resources. If every DNA lesion in a cell were repaired, avoiding mutations altogether, the cellular cost associated with performing that repair would have to increase in direct proportion to the amount of damage. In conditions of high DNA damage—through exposure to environmental mutagens, for example—DNA repair could be too costly for cellular survival. Instead, if restrictions or thresholds were placed on DNA quality control to perform some repair but not necessarily of all lesions, then DNA-repair–limited cells are more likely to survive than cells caught in comprehensive repair, which can lead to cell death (apoptosis). This implies that DNA quality control pathways are fully functional but naturally permissive of mutagenesis, even in normal cells.

Evidence to support this hypothesis comes from experiments in which induced pluripotent stem cells (iPSCs) were treated with an array of environmental genotoxins (12). These normal stem cells accumulated extensive passenger mutations showing distinct mutational signatures. Some mutational signatures showed transcriptional strand bias—whereby the nontranscribed DNA strand is more heavily mutated than the transcribed strand (12), the mark of transcription-coupled repair (TCR) activity. TCR fixes DNA damage on both strands, but preferentially on the transcribed strand, and its activity in normal cells was comparable to that in cancer cells. Accordingly, in iPSCs and cancer cells, the presence of strand bias indicates that TCR is competent and operative, but unable to mitigate all DNA damage, and is thus tolerant of mutagenesis.

Limited DNA quality control during circumstances of high damage has been suggested through mathematical modeling (13). The model shows that in a situation where individual DNA damaging events are rarely deleterious (that is, when most mutations are passengers) during periods of high damage, DNA-repair–unlimited cells incur high repair costs and become depleted owing to cell death. By contrast, DNA-repair–limited cells may continue with cell division and survive (see supplementary movies S1 and S2). This model could be a useful starting point to explore permissiveness to mutagenesis. Given that most (∼98%) of the genome is intronic and intergenic and the majority of mutations that arise as a result of DNA damage are unlikely to affect protein function, the model might explain why normal, healthy cells show considerable amounts of mutagenesis: survival through tolerance of mutation, rather than compromised DNA quality control processes.

The tolerance of mutagenesis in normal cells can, however, lead to the occurrence of new drivers, but not necessarily cancer. For example, in the testes of older men, acquired mutations in genes encoding components of receptor tyrosine kinase–RAS–mitogen-activated protein kinase (MAPK) and fibroblast growth factor receptor (FGFR) signaling pathways, which are commonly associated with cancer, result in increased cellular proliferation rates but seldom cause cancer. Clonal populations of seminiferous tubules generate spermatozoa with these mutations. This explains the high spontaneous birth prevalence and strong paternal age-effect of disorders such as achondroplasia, Apert, and Costello syndromes—all associated with activating mutations in MAPK and FGFR signaling genes. A study of 276 testicular biopsies obtained from five older men (median age of 83) identified additional cancer gene variants, all known to activate RAS-MAPK signaling (14). The aging male germ line therefore accumulates deleterious cancer driver mutations that rarely (if ever) switch to malignancy.

Another example is segmental overgrowth syndromes caused by somatic mutations of the cancer gene, PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit α). Although these syndromes are benign in terms of oncology, they can produce debilitating clinical phenotypes with unrelenting tissue growth (15). Referred to as PIK3CA-related overgrowth syndromes (PROS), affected people are mosaics, wherein discrete clonal populations exhibit mutations. The most frequent PIK3CA mutations in PROS (Glu542Lys, Glu545Lys, and His1047Arg) are identical to hotspot cancer driver mutations although other, non–cancer-associated PIK3CA mutations also occur in PROS. Notably, surrounding cells in affected tissues that are not PIK3CA-mutated are also overgrown (15). It has consequently been suggested that PIK3CA-mutated cells do not simply possess cell-autonomous characteristics, they may exert proliferation-enhancing properties on neighboring, non–PIK3CA-mutated cells.

Mutagenesis in normal tissue

DNA repair pathways permit some damage, resulting in mutagenesis but not necessarily cancer. Most normal tissues are likely to have many clonal populations defined by the distinct set of mutations that they harbor.

GRAPHIC: A. KITTERAN/SCIENCE

Therefore, driver mutations alone are not sufficient to initiate cancer, although they can be disease-causing. Considering that an adult human has ∼30 trillion cells, and only one cell develops into a cancer, human cells are remarkably robust at preventing cancer. Because the burden of mutagenesis and the frequencies of driver mutations can be high in normal tissues, mutations alone are possibly not sufficient to initiate cancer. Additional extrinsic factors, including cellular interactions and the microenvironment, seem to be required to create a selective environment that triggers a cell to become a dominant cancer clone. It is likely that the mutated genome of a cell contributes to the potential for malignant transformation, but it is not deterministic of it. This concept is not unfamiliar: Inherited mutations in DNA repair genes, such as BRCA1, BRCA2, and MLH1 (mutL homolog 1), cause familial cancer predisposition. They confer an increased lifetime risk of cancer, but cancer does not always arise. Additional factors seem to be required to tip the balance toward cancer development.

Mutagenesis remains important to explore. Identifying clinically relevant drivers and mutational signatures should provide meaningful directions for patient stratification and prognostication. The use of specific driver mutations is a favored method for patient stratification in clinical studies. However, a cancer gene could play disparate roles in tumors affecting different organs, and its functionality could evolve over the patient’s lifetime. Given the mutagenesis observed in normal tissues, perhaps it is time to reflect on whether this is the best approach for stratification. Similarly, although many mutational signatures have been identified, only a subset are clinically instructive—some may occur normally and not be causative of cancer. Others may be biomarkers of DNA repair deficiencies, which are potentially informative for therapy selection. It is imperative to identify mutations that are truly clinically meaningful, to improve cancer management.

Acknowledgments: Thanks to M. Hall for valuable discussions. B.A.H. is supported by the Royal Society (grant no. UF130039). S.N.-Z. is supported by a Cancer Research UK (CRUK) Advanced Clinician Scientist Award (C60100/A23916) and the Josef Steiner Foundation. Both authors are supported by a Medical Research Council (MRC) Grant-in-Aid to the MRC Cancer unit.

usscmc

usscmc

No Result
View All Result

Recent Posts

  • Volkswagen Announces Pricing of 25% Equity Stake Sale in Porsche
  • Can software simplify the supply chain? Ryan Petersen thinks so
  • A strategic approach to cost reduction for banks and fintechs
  • Study examines supply chain issues and opportunities
  • Instacart acquires hyper local grocery e-commerce platform

Recent Comments

  • Top 5 Supply Chain Certifications that are in high demand | Top 5 Certifications on Top 5 Globally Recognized Supply Chain Certifications
  • 3 Best Procurement Certifications that are most valuable | Procurement Newz on Top 5 Globally Recognized Supply Chain Certifications

Archives

  • September 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • September 2019

Categories

  • Global News
  • Supply Chain Updates

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org

slot gacor slot slot gacor 2023 slot 2023 slot gacor terbaru slot gacor terpercaya slot gacor slot gacor slot slot gacor 2023 slot 2023 slot gacor terbaru slot gacor terpercaya slot gacor slot gacor slot slot gacor 2023 slot 2023 slot gacor terbaru slot gacor terpercaya slot gacor

Pages

  • Home
  • Terms of Use
  • Privacy Policy
  • Disclaimer
  • Antispam
  • Contact Us

Categories

  • Global News
  • Supply Chain Updates
slot gacor slot slot gacor 2023 slot 2023 slot gacor terbaru slot gacor terpercaya slot gacor slot gacor slot slot gacor 2023 slot 2023 slot gacor terbaru slot gacor terpercaya slot gacor slot gacor slot slot gacor 2023 slot 2023 slot gacor terbaru slot gacor terpercaya slot gacor

Tags

APICS Globally Recognized Supply Chain Certifications IIPMR Certifications International Institute for Procurement and Market Research (IIPMR) ISM Next Level Purchasing Top 5 Supply Chain Certifications top supply chain certifications

Trending

No Content Available
  • Antispam
  • Contact Us
  • Disclaimer
  • Home
  • Privacy Policy
  • Terms of Use

© 2023 www.usscmc.com

No Result
View All Result
  • Home
  • Supply Chain Updates
  • Global News
  • Contact Us

© 2023 www.usscmc.com

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPT
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.

SAVE & ACCEPT